<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241030063550N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-02-07</date_registration>
      <primary_sponsor>National University Of Medical Sciences</primary_sponsor>
      <public_title>Effect of Cooler Dialysate Temperature on Haemodynamic Stability in Hypotensive Patients on Maintenance Haemodialysis</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Cooler Dialysate Temperature on Haemodynamic Stability in Hypotensive Patients on Maintenance Haemodialysis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-09-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/81745</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random allocation in this study is achieved using a computer-generated randomization sequence, prepared by an independent statistician who is not involved in the trial's conduct. Participants are assigned to either the cooler dialysate (35.5°C) or standard dialysate (37°C) group in a 1:1 ratio, with allocation concealed using sealed, opaque envelopes. These envelopes are opened only after participant enrollment by an independent technician, who then programs the dialysis machines accordingly, ensuring that neither participants nor healthcare providers can influence or predict group assignment. This method ensures a robust and unbiased randomization process, Blinding description: This study is a double-blind randomized controlled trial investigating the effect of cooler dialysate temperature on hemodynamic stability in hypotensive patients undergoing maintenance hemodialysis. Both participants and healthcare providers, including physicians and nurses, are blinded to the dialysate temperature settings. The dialysis machines are pre-programmed by an independent technician, and the temperature display is concealed to prevent unblinding. Data collectors and outcome assessors are also blinded to group allocations, analyzing anonymized data without knowledge of the intervention. The principal investigator remains blinded during data collection and analysis to minimize bias. Additionally, the Data Safety and Monitoring Board (DSMB) reviews coded, anonymized data to ensure safety and efficacy without compromising blinding. This double-blind design ensures the integrity and reliability of the study outcomes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hypotension in Hemodialysis patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: standard 4hrs hemodialysis with fresenius 4008 series hemodialysis machines, with standard flow rate of 450 to 500ml per min, with cooler dialysate temperature (35.5°C). Intervention 2: Control group: standard 4hrs hemodialysis with fresenius 4008 series hemodialysis machines, with standard flow rate of 450 to 500ml per min, with standard dialysate temperature (37°C).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Effect of Cooler Dialysate Temperature on Haemodynamic Stability in Hypotensive Patients on Maintenance Haemodialysis

When:
Mar 25

To whom:
Anyone who requests via email after sharing purpose of requirement

Conditions:
After taking consent from authors

Where to obtain:
Via email request

How to obtain:
Email request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Muhammad Haseeb Lodhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rawalpindi</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 324 5105840</telephone>
        <email>hazahlodhi@gmail.com</email>
        <affiliation>National University Of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Haseeb Lodhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rawalpindi</address>
        <city>Rawalpindi</city>
        <country1>Pakistan</country1>
        <zip>46000</zip>
        <telephone>+92 324 5105840</telephone>
        <email>hazahlodhi@gmail.com</email>
        <affiliation>National University Of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients from both genders.
Ages between 18 to 60 years.
On twice weekly Hemodialysis.
Having systolic blood pressure (SBP) below 90mmHg or diastolic blood pressure (DBP) below 60mmHg or both.
Patients with SBP above 90mmHg or mean arterial pressure ≥ 65 on pharmacological support .</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients having thyroid disease, anaemia, taking anti-hypertensive medications, recent heart attack, not willing to participate and pregnant females.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N18</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic kidney disease (CKD)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: standard 4hrs hemodialysis with fresenius 4008 series hemodialysis machines, with standard flow rate of 450 to 500ml per min, with cooler dialysate temperature (35.5°C)</i_keyword>
      <i_keyword>Control group: standard 4hrs hemodialysis with fresenius 4008 series hemodialysis machines, with standard flow rate of 450 to 500ml per min, with standard dialysate temperature (37°C)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intradialytic hypotension comparison in patients of CKD on maintenance hemodialysis. Timepoint: During the HD session, intradialytic blood pressure and pulse rate changes were documented every hour and at the end of the session. Method of measurement: BP measured with Sphygmomonometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National University Of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-08-01</approval_date>
        <contact_name>Ethics committee of Pakistan Emirates Military Hospital</contact_name>
        <contact_address>Rawalpindi Rawalpindi Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
